Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients

A perspective on the use of heterogeneous catalysis to drive the waste-to-pharma concept is provided in this contribution based on the conversion of furanics to active pharmaceutical ingredients (APIs). The provided overview of the concept in this perspective article has been exemplified for two key...

Full description

Saved in:
Bibliographic Details
Published in:Molecules (Basel, Switzerland) Switzerland), 2021-11, Vol.26 (21), p.6738
Main Authors: Luque, Rafael, ALOthman, Zeid A, Balu, Alina M, Voskressensky, Leonid
Format: Article
Language:English
Subjects:
Acids
Alcohols - chemistry
Angina pectoris
APIs
Biological activity
Catalysis
Cellulose
Chemicals
Fixed bed reactors
furanics
Furosemide
Furosemide - chemistry
Glycerol
heterogeneous catalysis
Ingredients
Lignocellulose
Molecular Structure
Pharmaceuticals
waste-to-pharma
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A perspective on the use of heterogeneous catalysis to drive the waste-to-pharma concept is provided in this contribution based on the conversion of furanics to active pharmaceutical ingredients (APIs). The provided overview of the concept in this perspective article has been exemplified for two key molecule examples: Ancarolol and Furosemide.
ISSN:1420-3049
1420-3049
DOI:10.3390/molecules26216738